Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Equity Ratio (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Equity Ratio for 16 consecutive years, with 0.47 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Ratio rose 2.48% to 0.47 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.47, a 2.48% increase, with the full-year FY2024 number at 0.46, down 17.42% from a year prior.
  • Equity Ratio was 0.47 for Q3 2025 at Xtant Medical Holdings, up from 0.47 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.59 in Q3 2023 to a low of 0.46 in Q4 2024.
  • A 5-year average of 0.52 and a median of 0.53 in 2022 define the central range for Equity Ratio.
  • Biggest YoY gain for Equity Ratio was 152.04% in 2021; the steepest drop was 48.31% in 2021.
  • Xtant Medical Holdings' Equity Ratio stood at 0.56 in 2021, then increased by 0.47% to 0.57 in 2022, then decreased by 2.27% to 0.55 in 2023, then decreased by 17.42% to 0.46 in 2024, then grew by 3.5% to 0.47 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Equity Ratio are 0.47 (Q3 2025), 0.47 (Q2 2025), and 0.46 (Q1 2025).